Showing results (101-110 of 125) with videos related to

Sort By:
Pageof 13
Journal of the Neurological Sciences|March 19, 2010
Natalizumab plus interferon beta-1a reduces lesion formation in relapsing multiple sclerosisErnst-Wilhelm Radue, William H Stuart, Peter A Calabresi, et al.
Annals of Neurology|November 12, 2005
Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria"Chris H Polman, Stephen C Reingold, Gilles Edan, et al.
Neurology|December 15, 2025
Lipoic Acid for Treatment of Progressive Multiple Sclerosis: A Phase 2 Randomized Clinical TrialRebecca I Spain, M Mateo Paz Soldán, Mark S Freedman, et al.
Multiple Sclerosis and Related Disorders|April 12, 2016
Relapses in multiple sclerosis: Relationship to disabilityDouglas S Goodin, Anthony T Reder, Robert A Bermel, et al.
Annals of Neurology|March 10, 2011
Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteriaChris H Polman, Stephen C Reingold, Brenda Banwell, et al.
Annals of Clinical and Translational Neurology|September 7, 2023
Anti-CD20 monoclonal antibody therapy in postpartum women with neurological conditionsAnnika Anderson, William Rowles, Shane Poole, et al.
Annals of Neurology|November 19, 2022
Dimethyl Fumarate Delays Multiple Sclerosis in Radiologically Isolated SyndromeDarin T Okuda, Orhun Kantarci, Christine Lebrun-Frénay, et al.
Nature Reviews. Neurology|August 3, 2026
Towards a biologically informed description of multiple sclerosis disease course - a roadmap for transitionAlan J Thompson, Fred D Lublin, Lindsay Rechtman, et al.
Journal of Neurology|March 25, 2009
The efficacy of natalizumab in patients with relapsing multiple sclerosis: subgroup analyses of AFFIRM and SENTINELMichael Hutchinson, Ludwig Kappos, Peter A Calabresi, et al.
Pageof 13